| No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
| 1 |
chr7:127761000-127762400 |
Enhancers |
Fetal Thymus |
thymus
|
| 2 |
chr7:127761000-127763400 |
Enhancers |
Fetal Brain Male |
brain
|
| 3 |
chr7:127761000-127763400 |
Enhancers |
Spleen |
Spleen
|
| 4 |
chr7:127761000-127763600 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
| 5 |
chr7:127761400-127762400 |
Bivalent/Poised TSS |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
| 6 |
chr7:127761400-127762400 |
Enhancers |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
| 7 |
chr7:127761400-127762800 |
Active TSS |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
| 8 |
chr7:127761400-127763000 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
| 9 |
chr7:127761400-127763400 |
Weak transcription |
ES-UCSF4 Cell Line |
embryonic stem cell
|
| 10 |
chr7:127761400-127763400 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
| 11 |
chr7:127761600-127762400 |
Flanking Active TSS |
Primary monocytes fromperipheralblood |
blood
|
| 12 |
chr7:127761600-127762400 |
Active TSS |
Muscle Satellite Cultured Cells |
--
|
| 13 |
chr7:127761600-127762400 |
Flanking Active TSS |
Adipose Nuclei |
Adipose
|
| 14 |
chr7:127761600-127762400 |
Flanking Active TSS |
Ovary |
ovary
|
| 15 |
chr7:127761600-127762400 |
Active TSS |
Right Atrium |
heart
|
| 16 |
chr7:127761600-127762400 |
Bivalent/Poised TSS |
K562 |
blood
|
| 17 |
chr7:127761600-127762600 |
Flanking Active TSS |
NHEK |
skin
|
| 18 |
chr7:127761600-127762800 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
| 19 |
chr7:127761800-127762400 |
Flanking Active TSS |
Breast Myoepithelial Primary Cells |
Breast
|
| 20 |
chr7:127761800-127762400 |
Active TSS |
Brain Substantia Nigra |
brain
|
| 21 |
chr7:127761800-127762600 |
Enhancers |
Primary B cells from cord blood |
blood
|
| 22 |
chr7:127761800-127763000 |
Enhancers |
Esophagus |
oesophagus
|
| 23 |
chr7:127761800-127763200 |
Enhancers |
Placenta |
Placenta
|
| 24 |
chr7:127761800-127763400 |
Flanking Active TSS |
Primary neutrophils fromperipheralblood |
blood
|
| 25 |
chr7:127761800-127764200 |
Enhancers |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
| 26 |
chr7:127762000-127762400 |
Flanking Active TSS |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
| 27 |
chr7:127762000-127762400 |
Flanking Active TSS |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
| 28 |
chr7:127762000-127762400 |
Enhancers |
Fetal Brain Female |
brain
|
| 29 |
chr7:127762000-127764800 |
Weak transcription |
Primary T cells from cord blood |
blood
|
| 30 |
chr7:127762200-127762400 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
| 31 |
chr7:127762200-127762400 |
Bivalent/Poised TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
| 32 |
chr7:127762200-127762400 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
| 33 |
chr7:127762200-127762400 |
Active TSS |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
| 34 |
chr7:127762200-127762400 |
Flanking Active TSS |
Fetal Kidney |
kidney
|
| 35 |
chr7:127762200-127762400 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
| 36 |
chr7:127762200-127762400 |
Bivalent Enhancer |
Skeletal Muscle Male |
skeletal muscle
|
| 37 |
chr7:127762200-127762400 |
Flanking Active TSS |
Osteobl |
bone
|
| 38 |
chr7:127762200-127762800 |
Weak transcription |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
| 39 |
chr7:127762200-127763000 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
| 40 |
chr7:127762200-127764200 |
Enhancers |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
| 41 |
chr7:127762200-127764200 |
Bivalent Enhancer |
HepG2 |
liver
|
